METROPOLIS Metropolis Healthcare Q1 FY26 results (Apr–Jun 2025) and concall
Metropolis Healthcare reported a robust Q1 FY26, with group revenue up 23.2% and organic revenue growing 13.2%. Profitability saw an uptrend, with organic EBITDA margin at 24.7% and PAT up 21.2%. The company successfully integrated recent acquisitions and announced a new one, while expanding its network and piloting new service lines like basic radiology, positioning for continued growth and margin improvement.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 |
|---|---|---|---|
| Revenue | 11 | 4 | 23 |
| EBITDA | 72 | 62 | 90 |
| Net profit | 31 | 29 | 45 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
